THE DEGRADATION OF 5'-DEOXY-5-FLUOROURIDINE BY PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN NORMAL AND CANCER TISSUES

被引:19
|
作者
CHOONG, YS [1 ]
LEE, SP [1 ]
机构
[1] UNIV AUCKLAND,SCH MED,DEPT MED,AUCKLAND,NEW ZEALAND
关键词
D O I
10.1016/0009-8981(85)90331-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:175 / 183
页数:9
相关论文
共 50 条
  • [21] Thymidine phosphorylase and 5-fluorouracil concentration in tumors and regional lymph nodes of breast cancer after 5′-deoxy-5-fluorouridine administration
    Inamoto, T
    Kawashima, H
    Yamauchi, A
    Ueno, M
    Matsutani, Y
    Yamaoka, Y
    22ND CONGRESS OF THE INTERNATIONAL ASSOCIATION FOR BREAST CANCER RESEARCH, 1999, : 221 - 224
  • [22] PHARMACOKINETIC STUDIES OF 5-FLUOROURACIL AND 5'-DEOXY-5-FLUOROURIDINE IN RATS
    AU, JLS
    WALKER, JS
    RUSTUM, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1983, 227 (01): : 174 - 180
  • [23] 5'-DEOXY-5-FLUOROURIDINE (5-DFUR), A NEW TUMOR-INHIBITING PYRIMIDINE ANTI-METABOLITE
    HARTMANN, HR
    BOLLAG, W
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 110 (27-2) : 1078 - 1080
  • [24] KINETICS AND METABOLISM OF A NEW FLUOROPYRIMIDINE, 5'-DEOXY-5-FLUOROURIDINE, IN HUMANS
    SOMMADOSSI, JP
    AUBERT, C
    CANO, JP
    GOUVEIA, J
    RIBAUD, P
    MATHE, G
    CANCER RESEARCH, 1983, 43 (02) : 930 - 933
  • [25] Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes
    Mimori, K
    Ueo, H
    Kuroki, T
    Shiraishi, T
    Creer, S
    Taylor, S
    Ishii, H
    Mori, M
    ONCOLOGY REPORTS, 2004, 12 (01) : 19 - 23
  • [26] Enhancement of the anti-tumor effect of 5′-deoxy-5-fluorouridine by transfection of thymidine phosphorylase gene into human colon cancer cells
    Kanyama, H
    Tomita, N
    Yamano, T
    Miyoshi, Y
    Ohue, M
    Fujiwara, Y
    Sekimoto, R
    Sakita, I
    Tamaki, Y
    Monden, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (04): : 454 - 459
  • [27] MECHANISM OF CYTO-TOXIC ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE
    ARMSTRONG, RD
    CONNOLLY, KM
    KAPLAN, AM
    CADMAN, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (02) : 102 - 105
  • [28] Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models
    Endo, M
    Shinbori, N
    Fukase, Y
    Sawada, N
    Ishikawa, T
    Ishitsuka, H
    Tanaka, Y
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (01) : 127 - 134
  • [29] EFFECT OF URIDINE COADMINISTRATION ON 5'-DEOXY-5-FLUOROURIDINE DISPOSITION IN RATS
    AU, JL
    WIENTJES, MG
    BRAMER, SL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (01) : 5 - 10
  • [30] BIOCHEMICAL BASIS FOR THE SUPERIOR THERAPEUTIC INDEX OF 5'-DEOXY-5-FLUOROURIDINE
    ARMSTRONG, RD
    DIASIO, RB
    FEDERATION PROCEEDINGS, 1981, 40 (06) : 1728 - 1728